相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel Antifungal Drug Discovery Based on Targeting Pathways Regulating the Fungus-Conserved Upc2 Transcription Factor
Christina Gallo-Ebert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In Vitro Study of Sequential Fluconazole and Caspofungin Treatment against Candida albicans Biofilms
Semanti Sarkar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Azole Susceptibility and Transcriptome Profiling in Candida albicans Mitochondrial Electron Transport Chain Complex I Mutants
Nuo Sun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Elevated Chitin Content Reduces the Susceptibility of Candida Species to Caspofungin
Louise A. Walker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Molecular Mechanisms of Drug Resistance in Clinical Candida Species Isolated from Tunisian Hospitals
Jamel Eddouzi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Extracellular DNA Release Acts as an Antifungal Resistance Mechanism in Mature Aspergillus fumigatus Biofilms
Ranjith Rajendran et al.
EUKARYOTIC CELL (2013)
Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans
Ming-Jie Xiang et al.
FEMS YEAST RESEARCH (2013)
Mechanisms of Candida biofilm drug resistance
Heather T. Taff et al.
FUTURE MICROBIOLOGY (2013)
Analysis of a fungus-specific transcription factor family, the Candida albicans zinc cluster proteins, by artificial activation
Rebecca Schillig et al.
MOLECULAR MICROBIOLOGY (2013)
Can host receptors for fungi be targeted for treatment of fungal infections?
Scott G. Filler
TRENDS IN MICROBIOLOGY (2013)
Evolutionary Genomics of Salmonella enterica Subspecies (vol 4, e00579-12, 2013)
Prerak T. Desai et al.
MBIO (2013)
A Functional Variomics Tool for Discovering Drug-Resistance Genes and Drug Targets
Zhiwei Huang et al.
CELL REPORTS (2013)
Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
Benjamin Matteson Vincent et al.
PLOS BIOLOGY (2013)
Genetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations
Jessica A. Hill et al.
PLOS GENETICS (2013)
Exploring the Trypanosoma brucei Hsp83 Potential as a Target for Structure Guided Drug Design
Juan Carlos Pizarro et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment
Michael A. Pfaller
AMERICAN JOURNAL OF MEDICINE (2012)
Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo
Keunsook K. Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Azole Resistance by Loss of Function of the Sterol Δ5,6-Desaturase Gene (ERG3) in Candida albicans Does Not Necessarily Decrease Virulence
L. A. Vale-Silva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Exciting Developments in the Immunology of Fungal Infections
Gordon D. Brown et al.
CELL HOST & MICROBE (2012)
Immunoglobulins in Defense, Pathogenesis, and Therapy of Fungal Diseases
Arturo Casadevall et al.
CELL HOST & MICROBE (2012)
Dendritic Cells in Antifungal Immunity and Vaccine Design
Rene M. Roy et al.
CELL HOST & MICROBE (2012)
Gain-of-Function Mutations in UPC2 Are a Frequent Cause of ERG11 Upregulation in Azole-Resistant Clinical Isolates of Candida albicans
Stephanie A. Flowers et al.
EUKARYOTIC CELL (2012)
Treatment of candidiasis: insights from host genetics
Corine E. Delsing et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence
Florent Morio et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Breakthrough invasive mould infections in patients treated with caspofungin
Katy-Anna Phai Pang et al.
JOURNAL OF INFECTION (2012)
Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans
Hyeseung Lee et al.
MOLECULAR MICROBIOLOGY (2012)
CRS-MIS in Candida glabrata: sphingolipids modulate echinocandin-Fks interaction
Kelley R. Healey et al.
MOLECULAR MICROBIOLOGY (2012)
Characterization of the Chromosome 4 Genes That Affect Fluconazole-Induced Disomy Formation in Cryptococcus neoformans
Popchai Ngamskulrungroj et al.
PLOS ONE (2012)
Comparative Lipidomics in Clinical Isolates of Candida albicans Reveal Crosstalk between Mitochondria, Cell Wall Integrity and Azole Resistance
Ashutosh Singh et al.
PLOS ONE (2012)
The Hsp90 Co-Chaperone Sgt1 Governs Candida albicans Morphogenesis and Drug Resistance
Rebecca S. Shapiro et al.
PLOS ONE (2012)
Polyene antibiotic that inhibits membrane transport proteins
Yvonne Maria te Welscher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection
Weidong Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Hidden Killers: Human Fungal Infections
Gordon D. Brown et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida
Russell E. Lewis et al.
VIRULENCE (2012)
Lysine Deacetylases Hda1 and Rpd3 Regulate Hsp90 Function thereby Governing Fungal Drug Resistance
Nicole Robbins et al.
CELL REPORTS (2012)
Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
Sheena D. Singh-Babak et al.
PLOS PATHOGENS (2012)
Managing drug resistance in cancer: lessons from HIV therapy
Christoph Bock et al.
NATURE REVIEWS CANCER (2012)
Azole Resistance of Aspergillus fumigatus Biofilms Is Partly Associated with Efflux Pump Activity
Ranjith Rajendran et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
New Fks Hot Spot for Acquired Echinocandin Resistance in Saccharomyces cerevisiae and Its Contribution to Intrinsic Resistance of Scedosporium Species
Michael E. Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Functional Dissection of a Candida albicans Zinc Cluster Transcription Factor, the Multidrug Resistance Regulator Mrr1
Sabrina Schubert et al.
EUKARYOTIC CELL (2011)
Mitochondria and Fungal Pathogenesis: Drug Tolerance, Virulence, and Potential for Antifungal Therapy
Miguel Shingu-Vazquez et al.
EUKARYOTIC CELL (2011)
Interface of Candida albicans Biofilm Matrix-Associated Drug Resistance and Cell Wall Integrity Regulation
Jeniel E. Nett et al.
EUKARYOTIC CELL (2011)
Structures of Cryptococcus neoformans Protein Farnesyltransferase Reveal Strategies for Developing Inhibitors That Target Fungal Pathogens
Michael A. Hast et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia
Maiken Cavling Arendrup et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Regulatory Circuitry Governing Fungal Development, Drug Resistance, and Disease
Rebecca S. Shapiro et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2011)
Contribution of CgPDR1-Regulated Genes in Enhanced Virulence of Azole-Resistant Candida glabrata
Selene Ferrari et al.
PLOS ONE (2011)
SREBP Coordinates Iron and Ergosterol Homeostasis to Mediate Triazole Drug and Hypoxia Responses in the Human Fungal Pathogen Aspergillus fumigatus
Michael Blatzer et al.
PLOS GENETICS (2011)
Hsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms
Nicole Robbins et al.
PLOS PATHOGENS (2011)
Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007-2009
Jan W. M. van der Linden et al.
EMERGING INFECTIOUS DISEASES (2011)
Acquisition of Flucytosine, Azole, and Caspofungin Resistance in Candida glabrata Bloodstream Isolates Serially Obtained from a Hematopoietic Stem Cell Transplant Recipient
Florence Chapeland-Leclerc et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Changes in the Proteome of Candida albicans in Response to Azole, Polyene, and Echinocandin Antifungal Agents
Christopher F. Hoehamer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance
Alicia J. Zimbeck et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and Spain
Klaus Leth Mortensen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Epidemiology of Invasive Mycoses in North America
Michael A. Pfaller et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2010)
Genomic Plasticity of the Human Fungal Pathogen Candida albicans
Anna Selmecki et al.
EUKARYOTIC CELL (2010)
Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients
Emilia Siikala et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009
Ahmed Bueid et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity
K. Niimi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Genetic Basis of Candida Biofilm Resistance Due to Drug-Sequestering Matrix Glucan
Jeniel E. Nett et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy
Hugo Wurtele et al.
NATURE MEDICINE (2010)
Gene Expression Analysis, Proteomics, and Network Discovery
Sacha Baginsky et al.
PLANT PHYSIOLOGY (2010)
PKC Signaling Regulates Drug Resistance of the Fungal Pathogen Candida albicans via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90
Shantelle L. LaFayette et al.
PLOS PATHOGENS (2010)
Cryptococcus neoformans Overcomes Stress of Azole Drugs by Formation of Disomy in Specific Multiple Chromosomes
Edward Sionov et al.
PLOS PATHOGENS (2010)
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
Benjamin J. Park et al.
AIDS (2009)
Efflux-Mediated Antifungal Drug Resistance
Richard D. Cannon et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Functional Analysis of cis- and trans-Acting Elements of the Candida albicans CDR2 Promoter with a Novel Promoter Reporter System
Alix T. Coste et al.
EUKARYOTIC CELL (2009)
Remodeling of Global Transcription Patterns of Cryptococcus neoformans Genes Mediated by the Stress-Activated HOG Signaling Pathways
Young-Joon Ko et al.
EUKARYOTIC CELL (2009)
Conservation of the Sterol Regulatory Element-Binding Protein Pathway and Its Pathobiological Importance in Cryptococcus neoformans
Yun C. Chang et al.
EUKARYOTIC CELL (2009)
Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
Paul E. Verweij et al.
LANCET INFECTIOUS DISEASES (2009)
Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease
Leah E. Cowen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Biofilm Matrix Regulation by Candida albicans Zap1
Clarissa J. Nobile et al.
PLOS BIOLOGY (2009)
Acquisition of Aneuploidy Provides Increased Fitness during the Evolution of Antifungal Drug Resistance
Anna M. Selmecki et al.
PLOS GENETICS (2009)
Hsp90 Orchestrates Stress Response Signaling Governing Fungal Drug Resistance
Leah E. Cowen
PLOS PATHOGENS (2009)
Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin
Sheena D. Singh et al.
PLOS PATHOGENS (2009)
Potential basis for amphotericin B resistance in Aspergillus terreus
Gerhard Blum et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Stress, drugs, and evolution: The role of cellular signaling in fungal drug resistance
Leah E. Cowen et al.
EUKARYOTIC CELL (2008)
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage
Graeme N. Forrest et al.
JOURNAL OF INFECTION (2008)
Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains
Nico Dunkel et al.
MOLECULAR MICROBIOLOGY (2008)
An integrated platform of genomic assays reveals small-molecule bioactivities
Shawn Hoon et al.
NATURE CHEMICAL BIOLOGY (2008)
The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype
Leah E. Cowen
NATURE REVIEWS MICROBIOLOGY (2008)
Current options in antifungal pharmacotherapy
John Mohr et al.
PHARMACOTHERAPY (2008)
Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
Eveline Snelders et al.
PLOS MEDICINE (2008)
Stimulation of chitin synthesis rescues Candida albicans from echinocandins
Louise A. Walker et al.
PLOS PATHOGENS (2008)
A Ser678Pro substitution in fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus
Eleusa Maria F. Rocha et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans
Joachim Morschhaeuser et al.
PLOS PATHOGENS (2007)
Genome-wide expression and location analyses of the Candida albicans Tac1p regulon
Teresa T. Liu et al.
EUKARYOTIC CELL (2007)
Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates
Alix Coste et al.
EUKARYOTIC CELL (2007)
Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections
William J. Steinbach et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Resistance to echinocandin-class antifungal drugs
David S. Perlin
DRUG RESISTANCE UPDATES (2007)
A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations
E. Mellado et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans
Carol A. Munro et al.
MOLECULAR MICROBIOLOGY (2007)
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth
Patrick Vandeputte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Advances in combating fungal diseases: vaccines on the threshold
Jim E. Cutler et al.
NATURE REVIEWS MICROBIOLOGY (2007)
How to build a biofilm: a fungal perspective
Jill R. Blankenship et al.
CURRENT OPINION IN MICROBIOLOGY (2006)
Genetic architecture of Hsp90-dependent drug resistance
Leah E. Cowen et al.
EUKARYOTIC CELL (2006)
Antifungal effects on metabolite profiles of medically important yeast species measured by nuclear magnetic resonance spectroscopy
Muireann Coen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Aneuploidy and isochromosome formation in drug-resistant Candida albicans
Anna Selmecki et al.
SCIENCE (2006)
A drug-sensitive genetic network masks fungi from the immune system
Robert T. Wheeler et al.
PLOS PATHOGENS (2006)
Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans
M Sanguinetti et al.
INFECTION AND IMMUNITY (2006)
Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1
Sergey V. Balashov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Regulation of sterol metabolism in Candida albicans by the UPC2 gene
TC White et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Hsp90 potentiates the rapid evotution of new traits: Drug resistance in diverse fungi
LE Cowen et al.
SCIENCE (2005)
Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp isolates
S Park et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Cryptococcus neoformans resistance to echinocandins:: (1,3)β-glucan synthase activity is sensitive to echinocandins
MA Maligie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin
RE Gardiner et al.
MEDICAL MYCOLOGY (2005)
Rapid, high-throughput, multiplex, real-time PCR for identification of mutations in the cyp51A gene of Aspergillus fumigatus that confer resistance to itraconazole
SV Balashov et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Analysis of β-1,3-glucan assembly in Saccharomyces cerevisiae using a synthetic interaction network and altered sensitivity to caspofungin
G Lesage et al.
GENETICS (2004)
Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata:: Roles of calcium signaling and mitochondria
R Kaur et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Combination antifungal therapy
MD Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Three-dimensional models of wild-type and mutated forms of cytochrome P450 14α-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding
L Xiao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism
PM Silver et al.
EUKARYOTIC CELL (2004)
TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of candida albicans ABC transporters CDR1 and CDR2
AT Coste et al.
EUKARYOTIC CELL (2004)
Shuttle vectors for Candida albicans:: control of plasmid copy number and elevated expression of cloned genes
WJ Du et al.
CURRENT GENETICS (2004)
Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans
K Mukhopadhyay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Mechanism of fluconazole resistance in Candida albicans biofilms:: Phase-specific role of efflux pumps and membrane sterols
PK Mukherjee et al.
INFECTION AND IMMUNITY (2003)
Antifungal agents: mechanisms of action
FC Odds et al.
TRENDS IN MICROBIOLOGY (2003)
A point mutation in the 14α-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus
TM Diaz-Guerra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome p450 14α-demethylase
PA Mann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole
B Posteraro et al.
MOLECULAR MICROBIOLOGY (2003)
G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate
L Rodero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling
C Reinoso-Martin et al.
EUKARYOTIC CELL (2003)
Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin
D van Duin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate
JW Slaven et al.
FUNGAL GENETICS AND BIOLOGY (2002)
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients
S Perea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Aspergillosis case - Fatality rate: Systematic review of the literature
SJ Lin et al.
CLINICAL INFECTIOUS DISEASES (2001)
A three-dimensional model of lanosterol 14α-demethylase of Candida albicans and its interaction with azole antifungals
HT Ji et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Practice guidelines for the management of cryptococcal disease
MS Saag et al.
CLINICAL INFECTIOUS DISEASES (2000)
In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B
CB Moore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
The R467K amino acid substitution in Candida albicans sterol 14 alpha-demethylase causes drug resistance through reduced affinity
DC Lamb et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
